Friday , April 26 2024
Home / Tag Archives: covid-19 vaccine

Tag Archives: covid-19 vaccine

Novavax (NVAX) Stock Up 8% Yesterday as FDA Approves Updated Covid Vaccine but Is 6% Down Now

The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.  In a recent development, stocks of Novavax Inc (NASDAQ: NVAX) jumped 8.2% yesterday following the Food and Drug Administration’s (FDA) approval of its improved COVID-19 vaccine. However, it’s worth noting that in pre-market trading, the stock experienced a slight dip and is 6% down at the...

Read More »

5 Companies Lead the Race in Producing the First COVID-19 Vaccine

Five pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine. Wall Street is likewise on alert for banking on the first company to produce an efficient one.As the battle against the spread of coronavirus outbreak across the world intensifies, many companies are working to put themselves at the forefront in producing viable COVID-19 vaccine.Producing a vaccine for human testing and adoption to address the Coronavirus outbreak remains as crucial...

Read More »

Germany’s Angela Merkel in Quarantine after Contact with Coronavirus-Infected Doctor

Merkel’s quarantine does not mean she will stop her official business, as the leader will continue working from home. She will also have regular COVID-19 tests in the coming days. Coronavirus gives no quarter to anyone, all of us can become at risk. Outstanding political leaders are no exception, and German Chancellor Angela Merkel has already checked it by her own experience. Currently, her ability to remain the public face of the country is under question, as after contact with...

Read More »

Moderna (MRNA) Stock Down 10.48% after FDA Commissioner Comments on Vaccine Timeline

Moderna (MRNA) stock tanked by 10.48% on Thursday. The slide followed FDA Stephen Huhn’s statement that the COVID-19 vaccine is at least a year away.After a short upward, Moderna Inc (NASDAQ: MRNA) stock has plunged. Yesterday, it closed at $28.27, 10.48% down from the previous mark. Before, Moderna stock had a sweet period, albeit short, accompanied by the positive coronavirus news.Moderna (MRNA) Stock PriceOn March 16, the biotech company dosed the first patient in a study of its...

Read More »